Illness perceptions and quality of life in Japanese and Dutch patients with non-small-cell lung cancer

Kaptein, Ad A.; Yamaoka, Kazue; Snoei, Lucia; Kobayashi, Kunihiko; Uchida, Yuka; Kloot, Willem A. van der; Tabei, Toshio; Kleijn, Wim Chr.; Koster, M.; Wijnands, Giel J.A.; Kaajan, Hans; Tran, Tommy; Inoue, Kentaro; Klink, Rik van; Dooren-Coppens, Eva van; Dik, Hans; Hayashi, Fumi; Willems, L. N. A.; Annema-Schmidt, Dunja; Annema, Jouke T.; Maat, Bas van der; Kralingen, Klaas van; Meirink, Corrie; Ogoshi, Kyoji; Aaronson, Neil K.; Nortier, Hans; Rabe, Klaus F.

doi:10.1016/j.lungcan.2010.09.010

Cited by 47 publications

(38 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In contrast, the social functional domain QOL of the patients in this study improved significantly after chemotherapy, as reported previously (Dai et al, 2015;Helsing et al, 1998;Kaptein et al, 2011). Most of our patients were over 65 years old.…”

Section: Discussionsupporting

confidence: 78%

See 1 more Smart Citation

Changes in and Determinants of Quality of Life in Patients With Advanced Non-Small-Cell Lung Cancer Undergoing Initial Chemotherapy

Dai

Yang

Chen

et al. 2017

Journal of Nursing Research

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 78%

“…of patients with advanced NSCLC has been shown to vary by cycle of chemotherapy (Kaptein et al, 2011). Although NCCN (2014) treatment guidelines recommend that first-line chemotherapy should not exceed four-to-six cycles, current clinical practice favors using four cycles of chemotherapy based on the tolerance of each patient.…”

mentioning

confidence: 99%

Changes in and Determinants of Quality of Life in Patients With Advanced Non-Small-Cell Lung Cancer Undergoing Initial Chemotherapy

Dai

Yang

Chen

et al. 2017

Journal of Nursing Research

View full text Add to dashboard Cite

show abstract

“…( 3 , 5 ) It has been suggested that patients with lung cancer experience greater symptom-related distress than do patients with other types of cancer, especially near the end of life. ( 3 ) Fatigue, pain, dyspnea, depression, and sleep disturbances appear to be the most common symptoms in lung cancer patients.…”

Section: Introductionmentioning

confidence: 99%

Relação entre a magnitude de sintomas e a qualidade de vida: análise de agrupamentos de pacientes com câncer de pulmão no Brasil

et al. 2013

View full text Add to dashboard Cite

OBJECTIVE: Lung cancer patients often experience profound physical and psychosocial changes as a result of disease progression or treatment side effects. Fatigue, pain, dyspnea, depression, and sleep disturbances appear to be the most common symptoms in such patients. The objective of the present study was to examine the prevalence of symptoms in lung cancer patients in order to identify subgroups (clusters) of patients, grouped according to the magnitude of the symptoms, as well as to compare the quality of life among the identified subgroups. METHODS: A cross-sectional study involving agglomerative hierarchical clustering. A total of 50 lung cancer patients were evaluated in terms of their demographic characteristics and their scores on three quality of life questionnaires, namely the 30-item European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30), the Functional Assessment of Cancer Therapy-Lung, and the Medical Outcomes Study 36-item Short-form Survey. The cluster analysis took into account the magnitude of the most prevalent symptoms as assessed by the EORTC QLQ-C30 symptom scale scores; those symptoms were fatigue, pain, dyspnea, and insomnia. RESULTS: Three clusters (subgroups)_of patients were identified on the basis of the magnitude of the four most prevalent symptoms. The three subgroups of patients were as follows: patients with mild symptoms (n = 30; 60%); patients with moderate symptoms (n = 14; 28%); and patients with severe symptoms (n = 6; 12%). The subgroup of patients with severe symptoms had the worst quality of life, as assessed by the total scores and by the integrated domains of all three instruments. CONCLUSIONS: This study highlights the importance of symptom cluster assessment as an important tool to assess the quality of life of patients with chronic diseases, such as lung cancer.

show abstract

“…DIF occurs when subgroups respond differently to items despite equal levels of the underlying construct, and can thus complicate or invalidate between-group score comparisons. Many studies seek to compare illness perception scores between different disease or sociodemographic groups [22,28,29]. Therefore, we aimed to use Rasch analysis to explore the extent to which the IPQ-R items function uniformly across clinical and sociodemographic subgroups.…”

mentioning

confidence: 99%

Psychometric evaluation of the Revised Illness Perception Questionnaire (IPQ-R) in cancer patients: Confirmatory factor analysis and Rasch analysis

Ashley

Smith

Keding

et al. 2013

Journal of Psychosomatic Research

View full text Add to dashboard Cite

Illness perceptions and quality of life in Japanese and Dutch patients with non-small-cell lung cancer

Cited by 47 publications

References 46 publications

Changes in and Determinants of Quality of Life in Patients With Advanced Non-Small-Cell Lung Cancer Undergoing Initial Chemotherapy

Changes in and Determinants of Quality of Life in Patients With Advanced Non-Small-Cell Lung Cancer Undergoing Initial Chemotherapy

Relação entre a magnitude de sintomas e a qualidade de vida: análise de agrupamentos de pacientes com câncer de pulmão no Brasil

Psychometric evaluation of the Revised Illness Perception Questionnaire (IPQ-R) in cancer patients: Confirmatory factor analysis and Rasch analysis

Contact Info

Product

Resources

About